Hearing Status and Aural Rehabilitative Profile of 878 Patients With Sporadic Vestibular Schwannoma
- PMID: 33296080
- DOI: 10.1002/lary.29315
Hearing Status and Aural Rehabilitative Profile of 878 Patients With Sporadic Vestibular Schwannoma
Abstract
Objectives/hypothesis: To examine the hearing status and aural rehabilitative profile in a national cohort of patients with sporadic vestibular schwannoma (VS).
Study design: Cross-sectional survey METHODS: A cross-sectional survey of Acoustic Neuroma Association members diagnosed with sporadic VS was performed from February 2017 through January 2019. Self-reported results were used to determine the aural rehabilitative profile of respondents.
Results: Among survey respondents, 62.2% (546/878) were not using any hearing-assistive device at time of survey. For the 37.8% (332/878) that were utilizing hearing-assistive devices, 32.8% (109/332) reported using a behind-the-ear hearing aid, 23.8% (79/332) used a contralateral routing of signal (CROS) hearing aid, and 21.7% (72/332) used a bone conduction device. Notably, 41.9% (278/663) of patients who previously underwent tumor treatment reported utilizing a hearing rehabilitation device at some point during VS management compared to 27.0% (58/215) of those undergoing observation with serial imaging (P < .001). Of 275 patients with functional hearing in the ipsilateral ear, 26.5% (73/275) reported having used at least one type of hearing device; 24.0% (66/275) reported use of a conventional hearing aid, 0.7% (2/275) a CROS aid, and 0.4% (1/275) a bone conduction device. Among respondents reporting ipsilateral nonfunctional hearing, 44.9% (258/575) reported having used at least one type of hearing device; 13.0% (75/575) a CROS aid, and 12.3% (71/575) a bone conduction device.
Conclusions: Even among a cohort with presumably elevated literacy surrounding hearing rehabilitation options, few patients with a history of unilateral vestibular schwannoma ultimately use hearing assistive devices long-term, suggesting that most patients sufficiently adjust to unilateral hearing loss or are unsatisfied with the benefits achieved with current device options.
Level of evidence: 4 Laryngoscope, 131:1378-1381, 2021.
Keywords: Acoustic Neuroma Association; Vestibular schwannoma; acoustic neuroma; hearing; quality of life; rehabilitation.
© 2020 American Laryngological, Rhinological and Otological Society Inc, "The Triological Society" and American Laryngological Association (ALA).
References
REFERENCES
-
- Lees KA, Tombers NM, Link MJ, et al. Natural history of sporadic vestibular schwannoma: a volumetric study of tumor growth. Otolaryngol Head Neck Surg 2018;159:535-542.
-
- Carlson ML, Tveiten OV, Driscoll CL, et al. Long-term quality of life in patients with vestibular schwannoma: an international multicenter cross-sectional study comparing microsurgery, stereotactic radiosurgery, observation, and nontumor controls. J Neurosurg 2015;122:833-842.
-
- Carlson ML, Tveiten OV, Driscoll CL, et al. What drives quality of life in patients with sporadic vestibular schwannoma? Laryngoscope 2015;125:1697-1702.
-
- Carlson ML, Vivas EX, McCracken DJ, et al. Congress of Neurological Surgeons systematic review and evidence-based guidelines on hearing preservation outcomes in patients with sporadic vestibular schwannomas. Neurosurgery 2018;82:E35-E39.
-
- Dowling EM, Patel NS, Lohse CM, et al. Durability of hearing preservation following microsurgical resection of vestibular schwannoma. Otol Neurotol 2019;40:1363-1372.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
